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determined it was 113.8±68.8 (iv 6-324) months. Applying the new set of criteria we determined 
that the mean number of criteria was 7.21±1.46, varying from 5 to 11 criteria, equivalent to 
91.4±14.5 percent, which represents a defined diagnosis. Age at onset of first symptom ≥ 18 and 
< 40 years was determined in 35.4 % and more than 40 years had 64.6 % of study patients, 
specific for these diseases. Weakness of proximal upper extremities, usually progressive over 
time was appreciated in 98.5 % and of lower extremities-95.4 percent. Skin manifestation were 
represented by heliotrope rash observed in 33 (50.7%) patients and Gottron’s papules-24 (36.9%) 
cases. The presence of dysphagia was detected in 11 (16.9%) patients and anti-Jo-1 antibodies 
were found in 5 (7.7%) cases. It should be noted that the elevation of muscle enzymes were 
present in all patients. Muscle biopsy, optional in the new criteria, was done by 22 (33.8 %) 
patients and characteristic features were observed, the most frequent was endomysial infiltration 
of mononuclear cells surrounding, but not invading myofibres in 16 (24.6 %) cases.  
Conclusions. The new criteria set for the diagnosis and classification of idiopathic inflammatory 
myopathies is easy to apply and interpret, being useful in examining these patients. 
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Introduction. Sentinel lymph node (SLN) is defined as the first lymph node localized on the 
direct lymphatic drainage pathway from a primary tumor. The sentinel lymph node biopsy 
(SLNB) is largely used in breast cancer and melanoma but it may also be useful in other 
epithelial skin cancers as well as in tumors located in the upper or lower gastrointestinal tract, 
lungs, thyroid, cervix and vulva. SLNB in melanoma is essential for an accurate staging, to 
estimate the risk of extension to other lymph nodes or organs and to evaluate the prognosis. 
Melanoma, even if it is not as common as the basal cell carcinoma or squamous cell carcinoma 
among the skin tumors, presents an increasing incidence and a higher mortality. 
Aim of the study. To present an objective image of the SLNB practice in two county clinical 
hospitals: Azienda Ospedaliero-Universitaria di Parma (AOUP), Italy and Spitalul Clinic 
Judetean Mures (SCJM), Romania, as well as the outcomes of the microscopic analysis. 
Materials and methods. Our study analyses the case-book records of the Pathology Department 
in two county clinical hospitals from 2012 to 2016. Tissue fragments obtained as a result of 
surgical excisions were processed using standard histological methods: fixing in formalin for 12- 
24 hours, embedding in paraffin, multiple sectioning, staining with hematoxyline-eosine and 
performing immunohistochemistry using MelanA, S100, HMB45. 
Results. During our study, 1594 tumors were analyzed. After eliminating insitu, acral-lentiginous 
and mucosal melanomas, we included in the statistical analysis 660 lesions diagnosed at AOUP 
and 67 at SCJM. The SLNB technique was performed in approximately 30% of the patients at 
AOUP and 49% at SCJM. The study shows a relative equal distribution between the two centers 
regarding the positivity or negativity of the SLN, respectively 85% versus 15%. Despite the 
slight difference between the number of cases without a SLNB performed which may also be 
explained by the larger number of patients at the AOUP, we obtained overlapping ratios for the 
positive and negative SLN. We have defined positive SLN as the lymph node presenting tumor 
invasion and negative SLN as the node without malignant cells in its structure. A positive SLN, 
identified in 15% of cases in both departments, may change the medical and surgical approach 
and allows the adjustment of the survival prognostic. 
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Conclusions. The status of the SLN, defined as the first lymph node to be involved in the 
metastatic spread, may change the medical or surgical approach, the follow-up and allows a 
precise staging, the calculation of the survival rates. The procedure should be executed for more 
cases in order to obtain a faithful result. 
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Introduction. Rheumatoid arthritis (RA) is a pathology that leads to functional impairment with 
functional deficits, affects the patient's normal activity and reduces its productivity. From an 
economic and social point of view, it has a negative impact on both his family and society, 
greatly reducing the quality of life of the patient. According to the WHO data, RA prevalence in 
the general population is 0.6 - 1.3% and annual incidence - 0.02%. RA is an inflammatory, 
autoimmune disease of unknown etiology, which has a chronic and progressive evolution, affects 
the joints by symmetrical erosive arthritis and can be associated with extraarticular and systemic 
manifestations.  
Aim of the study. To study the affection of the nervous system in patients with RA, to improve 
their quality of life. We have proposed to find effective ways to prevent infirmity through RA.  
Materials and methods. We studied files of 50 patients who were suffering from RA and 
analyzed the results. Also, we studied specialized information and international publications with 
impact on the study.  Of the 50 patients, 24 had oversegmental vegetative dysfunction with 
astenovegetative syndrome, 10 patients had paraesthesias, 4 patients had both. Of the 13 patients 
who had visceral RA, 10 of them had nerve damage.  
Results. have shown that the duration of the RA disease and the nervous disorder are not 
correlated. Patients with RA history less than 5 years are more likely to develop nerve 
complications. 10% of the RA patients had illness for less than 5 years, but they had already 
nerve damage, while 100% of patients without nervous disorder had RA more than 5 years. 
Autonomic dysfunction in RA patients is associated with disease activity. 77,4% of those with 
nervous disorder had DAS > 5,1, i.e. high disease activity. RA may induce neuropsychiatric 
disorders, affecting nervous system functions. Early detection of these disorders can prevent 
debilitating changes in the nervous system and improve the quality of life in patients with RA. 
Conclusions. The duration of the RA disease and the nerve damage are not correlated. Patients 
with RA history less than 5 years are more likely to develop nerve complications. Autonomic 
dysfunction in RA patients is associated with disease activity. Early detection of neuropsychiatric 
disorders allows prevention of debilitating changes in the nervous system. 
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